Literature DB >> 7851553

How should the axilla be treated in breast cancer? Why I favour axillary node clearance in the management of breast cancer.

T Davidson1.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7851553     DOI： 10.1016/s0748-7983(05)80057-5

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN： 0748-7983            Impact factor:   4.424


× No keyword cloud information.
  7 in total

1.  The reliability of sampling three to six nodes for staging breast cancer.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

Review 2.  Axillary staging of breast cancer and the sentinel node.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

3.  Prognostic value of the interpectoral lymph nodes in breast cancer. A 20-year survival study.

Authors:  A García-Vilanova Comas; A García Vilanova; E Fuster-Diana; N Martínez-Alzamora; Jm Fernández-Tena; J García-Vilanova Comas; M García-Vilanova Comas
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

4.  No significant correlation between oncogene protein expression and nodal status.

Authors:  M Noguchi
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

5.  Intraoperative assessment of axillary lymph node metastases in operable breast cancer.

Authors:  M Noguchi; M Minami; M Earashi; T Taniya; I Miyazaki; Y Mizukami; A Nonomura
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  Estimating the overlap between sentinel lymph nodes and axillary node samples in breast cancer.

Authors:  G Cserni
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 7.  Diagnosis of axillary lymph node metastases in patients with breast cancer.

Authors:  M Noguchi; N Katev; I Miyazaki
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.